To include your compound in the COVID-19 Resource Center, submit it here.
In an open-label U.S. Phase IIIb trial in 2,968 patients, switching to Adderall XR from other medications
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury